List view / Grid view

Dr Monther Abu-Remaileh (Assistant Professor of Chemical Engineering and Genetics at Stanford University)

 

news

Targeting PLA2G15 to treat neurometabolic disorders

Scenic Biotech and Stanford University have published a study identifying…

20 May 2025 | By

Scenic Biotech and Stanford University have published a study identifying PLA2G15 as a new drug target in neurodegenerative and metabolic diseases, potentially enabling future treatments for conditions like Niemann-Pick type C.